PubMed

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.

Liu-Seifert H, Adams DH, Kinon BJ.

BMC Med. 2005 Dec 23;3:21.PMID: 16375765 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.

Kinon BJ, Liu-Seifert H, Adams DH, Citrome L.

J Clin Psychopharmacol. 2006 Dec;26(6):632-7.PMID: 17110821 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.

Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2006 Apr;163(4):611-22.PMID: 16585435 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.

Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano GA, Rosenheck RA, Keefe RS, Miller AL, Belz I, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2007 Mar;164(3):415-27.PMID: 17329466 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.

Perkins DO, Gu H, Weiden PJ, McEvoy JP, Hamer RM, Lieberman JA; Comparison of Atypicals in First Episode study group.

J Clin Psychiatry. 2008 Jan;69(1):106-13.PMID: 18312044 [PubMed - indexed for MEDLINE]Related articles

The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials.

Kinon BJ, Ascher-Svanum H, Adams DH, Chen L.

J Clin Psychopharmacol. 2008 Oct;28(5):544-9.PMID: 18794651 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, Swartz MS, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2006 Apr;163(4):600-10.PMID: 16585434 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.

Wang X, Savage R, Borisov A, Rosenberg J, Woolwine B, Tucker M, May R, Feldman J, Nemeroff CB, Miller AH.

J Psychiatr Res. 2006 Oct;40(7):669-76. Epub 2006 Jun 9.PMID: 16762371 [PubMed - indexed for MEDLINE]Related articles

Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.

Mullins CD, Obeidat NA, Cuffel BJ, Naradzay J, Loebel AD.

Schizophr Res. 2008 Jan;98(1-3):8-15. Epub 2007 Jun 26.PMID: 17596914 [PubMed - indexed for MEDLINE]Related articles

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.PMID: 16707074 [PubMed - indexed for MEDLINE]Related articlesFree article

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.

Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L'Italien G, McQuade RD, Beuzen JN.

Eur Psychiatry. 2007 Oct;22(7):433-43. Epub 2007 Jun 7.PMID: 17555947 [PubMed - indexed for MEDLINE]Related articles

Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.

Yamashita H, Mori K, Nagao M, Okamoto Y, Morinobu S, Yamawaki S.

J Clin Psychiatry. 2004 Nov;65(11):1525-30.PMID: 15554767 [PubMed - indexed for MEDLINE]Related articles

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial.

Gharabawi GM, Greenspan A, Rupnow MF, Kosik-Gonzalez C, Bossie CA, Zhu Y, Kalali AH, Awad AG.

BMC Psychiatry. 2006 Oct 20;6:45.PMID: 17054789 [PubMed - indexed for MEDLINE]Related articlesFree article

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.

Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Reimherr F, Miller del D, McGee M, Khan A, Canive JM, Davis SM, Hsiao JK, Lieberman JA; CATIE Investigators.

Schizophr Res. 2008 Mar;100(1-3):39-52. Epub 2008 Jan 11.PMID: 18191383 [PubMed - indexed for MEDLINE]Related articles

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia.

Kinon BJ, Chen L, Ascher-Svanum H, Stauffer VL, Kollack-Walker S, Sniadecki JL, Kane JM.

Schizophr Res. 2008 Jul;102(1-3):230-40. Epub 2008 Apr 18.PMID: 18423985 [PubMed - indexed for MEDLINE]Related articles

[Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics]

Bartkó G, Trixler M, Bitter I, Degrell I, Füredi J, Faludi G; Ziprasidonra Váltást Vizsgáló Munkacsoport.

Neuropsychopharmacol Hung. 2006 Dec;8(4):201-9. Hungarian. PMID: 17211055 [PubMed - indexed for MEDLINE]Related articles

Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults.

Yamashita H, Mori K, Nagao M, Okamoto Y, Morinobu S, Yamawaki S.

Am J Geriatr Psychiatry. 2005 May;13(5):377-84.PMID: 15879586 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.

McEvoy JP, Lieberman JA, Perkins DO, Hamer RM, Gu H, Lazarus A, Sweitzer D, Olexy C, Weiden P, Strakowski SD.

Am J Psychiatry. 2007 Jul;164(7):1050-60.PMID: 17606657 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.

Ratner Y, Gibel A, Yorkov V, Ritsner MS.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1401-9. Epub 2007 Jun 21.PMID: 17669574 [PubMed - indexed for MEDLINE]Related articles

Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study.

Ganguli R, Brar JS, Mahmoud R, Berry SA, Pandina GJ.

BMC Med. 2008 Jun 30;6:17.PMID: 18590519 [PubMed - indexed for MEDLINE]Related articlesFree article